SCHEMBL27223511

SCHEMBL27223511

Fc1cccc(Nc2nc(NC3CCCCC3)c3ccccc3n2)c1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MERTK Q12866 6/20 0.75
▸ NPY5R Q15761 3/20 0.67
▸ PAK4 O96013 1/20 0.57
▸ KDM4E B2RXH2 1/20 0.57
▸ MEN1 O00255 1/20 0.57
▸ NPC1 O15118 1/20 0.57
▸ TP53 P04637 1/20 0.57
▸ ALOX15 P16050 1/20 0.57
▸ TSHR P16473 1/20 0.57
▸ RAB9A P51151 1/20 0.57
▸ KMT2A Q03164 1/20 0.57
▸ SMN1; SMN2 Q16637 1/20 0.57
▸ TAAR1 Q96RJ0 1/20 0.57
▸ HSD17B10 Q99714 1/20 0.57
▸ TLR7 Q9NYK1 1/20 0.54
▸ PDE5A O76074 1/20 0.53
▸ ACP1 P24666 1/20 0.53
▸ OGG1 O15527 1/20 0.53
▸ GBA1 P04062 1/20 0.53
▸ ADORA3 P0DMS8 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27223950 0.91 MERTK (0.78) MERTKNPY5RTLR7PDE5AACP1
SCHEMBL27224044 0.88 MERTK (0.81) MERTKNPY5RMEN1KMT2ATLR7
SCHEMBL24649758 0.87 MERTK (0.98) MERTKNPY5RTLR7PDE5AACP1
SCHEMBL30896250 0.87 MERTK (0.98) MERTKNPY5RTLR7PDE5AACP1
SCHEMBL30896246 0.86 MERTK (0.65) MERTKNPY5RTLR7PDE5AACP1
SCHEMBL27223336 0.86 MERTK (0.65) MERTKNPY5RPAK4PDE5AACP1
SCHEMBL30896206 0.86 MERTK (0.75) MERTKNPY5RTLR7PDE5AACP1
SCHEMBL24649804 0.86 MERTK (0.75) MERTKNPY5RTLR7PDE5AACP1
SCHEMBL30896201 0.86 MERTK (0.65) MERTKNPY5RPAK4PDE5AACP1
SCHEMBL27224015 0.86 MERTK (0.65) MERTKNPY5RTLR7PDE5AACP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240166626-A1 Compounds and Methods for Preventing, Treating, or Ameliorating Airway Disease UNIV JEFFERSON (US) 2024-05-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240166626-A1 Compounds and Methods for Preventing, Treating, or Ameliorating Airway Disease ADRB2, ADRB1, ADRB3 MERTK 3423/4885NPY5R 2011/4885PAK4 681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback